ptn_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934

 

Date of Report (Date of earliest event reported): May 11, 2023

 

Palatin Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-15543

 

95-4078884

(State or other jurisdiction

 

(Commission

 

(IRS employer

of incorporation)

 

File Number)

 

identification number)

 

4B Cedar Brook Drive, Cranbury, NJ

 

08512

(Address of principal executive offices)

 

(Zip Code)

 

Registrant's telephone number, including area code: (609) 495-2200

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading Symbol(s)

 

Name of Each Exchange on Which Registered

Common Stock

 

PTN

 

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

 

Emerging growth company

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 8.01 Other Events.

 

On May 11, 2023, Palatin Technologies, Inc. issued a press release announcing a conference call and live audio webcast to be held May 16, 2023. A copy of this press release is attached as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01    Financial Statements and Exhibits.

 

(d) Exhibits:

 

99.1

Press Release dated May 11, 2023

 

 
2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

PALATIN TECHNOLOGIES, INC.

 

 

 

 

 

Date: May 12, 2023

By:  

/s/ Stephen T. Wills  

 

 

 

Stephen T. Wills, CPA, MST

 

 

 

Executive Vice President, Chief Financial Officer and Chief Operating Officer

 

 

 
3

 

 

EXHIBIT INDEX

 

99.1

Press Release dated May 11, 2023

 

 
4

 

EXHIBIT 99.1

 

Palatin to Report Third Quarter Fiscal Year 2023 Results;

Teleconference and Webcast to be held on May 16, 2023

 

CRANBURY, N.J., May 11, 2023 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter fiscal year 2023 operating results on Tuesday, May 16, 2023, before the open of the U.S. financial markets.

 

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 16, 2023, at 11:00 a.m. ET. The conference call will include a review of the company’s operating results and an update on programs under development.

 

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast

 

Q3 Fiscal Year 2023 Results Press Release

 

05/16/2023 at 7:30 a.m. ET

 

 

 

Q3 Fiscal Year 2023 Conference Call-Live

 

05/16/2023 at 11:00 a.m. ET

US Toll Free Dial-In Number:

 

1-888-506-0062

International Dial-In Number:

 

1-973-528-0011

Participant Access Code:

 

555988

 

 

 

Q3 Fiscal Year 2023 Conference Call-Replay

 

05/16/2023-05/30/2023

US Toll Free Dial-In Number:

 

1-877-481-4010

International Dial-In Number:

 

1-919-882-2331

Participant Access Code:

 

48459

 

The audio webcast and replay can be accessed by logging on to the “Investors-Webcasts” section of Palatin’s website at http://www.palatin.com or by accessing this link.

  

About Palatin

 

Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.

  

Palatin Investor Inquiries:

Palatin Media Inquiries:

Stephen T. Wills, CPA, MST

Paul Arndt, MBA, LifeSci Advisors, LLC

Chief Operating Officer / Chief Financial Officer

Managing Director

Tel: (609) 495-2200 / [email protected]

Tel: (646) 597-6992 / [email protected]

 

###